You have to speculate with this stock. They said that they want to seek FDA approval and everyone knows that this is an expensive process and IF they want to get this "product" through easier and faster, they would seek to partner with a bigger Pharma that has been through the FDA process and is willing to co-finance the move and probably get a stock exchange for the deal, since CBIS is cash-strapped.
Just my opinion, but if we knew everything for certain, this stock would be at $5.00/share.
:o)